0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prenatal and Newborn Genetic Testing Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-7H7682
Home | Market Reports | Health| Reproductive Health
Global Prenatal and Newborn Genetic Testing Market Insights and Forecast to 2028
BUY CHAPTERS

Global Prenatal and Newborn Genetic Testing Market Research Report 2025

Code: QYRE-Auto-7H7682
Report
September 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Prenatal and Newborn Genetic Testing Market Size

The global market for Prenatal and Newborn Genetic Testing was valued at US$ 2388 million in the year 2024 and is projected to reach a revised size of US$ 3131 million by 2031, growing at a CAGR of 4.0% during the forecast period.

Prenatal and Newborn Genetic Testing Market

Prenatal and Newborn Genetic Testing Market

North American market for Prenatal and Newborn Genetic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Prenatal and Newborn Genetic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Prenatal and Newborn Genetic Testing in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Prenatal and Newborn Genetic Testing include Roche Diagnostic, Elitech Group, Myriad Genetics, Biocartis, IntegraGen, Perkin Elmer, WaferGen Biosystem, Interpace Diagnostics, Quest Diagnostic, Bio-Rad, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prenatal and Newborn Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prenatal and Newborn Genetic Testing.
The Prenatal and Newborn Genetic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prenatal and Newborn Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prenatal and Newborn Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Prenatal and Newborn Genetic Testing Market Report

Report Metric Details
Report Name Prenatal and Newborn Genetic Testing Market
Accounted market size in year US$ 2388 million
Forecasted market size in 2031 US$ 3131 million
CAGR 4.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Array-Comparative Genetic Hybridization(aCGH)
  • Fluorescence In-Situ Hybridization(FISH)
  • Polymerase Chain Reaction(PCR)
Segment by Application
  • Hospitals
  • Diagnostic Organization
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche Diagnostic, Elitech Group, Myriad Genetics, Biocartis, IntegraGen, Perkin Elmer, WaferGen Biosystem, Interpace Diagnostics, Quest Diagnostic, Bio-Rad, AutoGenomics, Abbott, Cepheid, EKF Diagnostics, Natera, Agilent Technologies, Illumina, Ariosa Diagnostics, Sequenom
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Prenatal and Newborn Genetic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Prenatal and Newborn Genetic Testing Market growing?

Ans: The Prenatal and Newborn Genetic Testing Market witnessing a CAGR of 4.0% during the forecast period 2025-2031.

What is the Prenatal and Newborn Genetic Testing Market size in 2031?

Ans: The Prenatal and Newborn Genetic Testing Market size in 2031 will be US$ 3131 million.

Who are the main players in the Prenatal and Newborn Genetic Testing Market report?

Ans: The main players in the Prenatal and Newborn Genetic Testing Market are Roche Diagnostic, Elitech Group, Myriad Genetics, Biocartis, IntegraGen, Perkin Elmer, WaferGen Biosystem, Interpace Diagnostics, Quest Diagnostic, Bio-Rad, AutoGenomics, Abbott, Cepheid, EKF Diagnostics, Natera, Agilent Technologies, Illumina, Ariosa Diagnostics, Sequenom

What are the Application segmentation covered in the Prenatal and Newborn Genetic Testing Market report?

Ans: The Applications covered in the Prenatal and Newborn Genetic Testing Market report are Hospitals, Diagnostic Organization, Other

What are the Type segmentation covered in the Prenatal and Newborn Genetic Testing Market report?

Ans: The Types covered in the Prenatal and Newborn Genetic Testing Market report are Array-Comparative Genetic Hybridization(aCGH), Fluorescence In-Situ Hybridization(FISH), Polymerase Chain Reaction(PCR)

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prenatal and Newborn Genetic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Array-Comparative Genetic Hybridization(aCGH)
1.2.3 Fluorescence In-Situ Hybridization(FISH)
1.2.4 Polymerase Chain Reaction(PCR)
1.3 Market by Application
1.3.1 Global Prenatal and Newborn Genetic Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostic Organization
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prenatal and Newborn Genetic Testing Market Perspective (2020-2031)
2.2 Global Prenatal and Newborn Genetic Testing Growth Trends by Region
2.2.1 Global Prenatal and Newborn Genetic Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Prenatal and Newborn Genetic Testing Historic Market Size by Region (2020-2025)
2.2.3 Prenatal and Newborn Genetic Testing Forecasted Market Size by Region (2026-2031)
2.3 Prenatal and Newborn Genetic Testing Market Dynamics
2.3.1 Prenatal and Newborn Genetic Testing Industry Trends
2.3.2 Prenatal and Newborn Genetic Testing Market Drivers
2.3.3 Prenatal and Newborn Genetic Testing Market Challenges
2.3.4 Prenatal and Newborn Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prenatal and Newborn Genetic Testing Players by Revenue
3.1.1 Global Top Prenatal and Newborn Genetic Testing Players by Revenue (2020-2025)
3.1.2 Global Prenatal and Newborn Genetic Testing Revenue Market Share by Players (2020-2025)
3.2 Global Prenatal and Newborn Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Prenatal and Newborn Genetic Testing Revenue
3.4 Global Prenatal and Newborn Genetic Testing Market Concentration Ratio
3.4.1 Global Prenatal and Newborn Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prenatal and Newborn Genetic Testing Revenue in 2024
3.5 Global Key Players of Prenatal and Newborn Genetic Testing Head office and Area Served
3.6 Global Key Players of Prenatal and Newborn Genetic Testing, Product and Application
3.7 Global Key Players of Prenatal and Newborn Genetic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prenatal and Newborn Genetic Testing Breakdown Data by Type
4.1 Global Prenatal and Newborn Genetic Testing Historic Market Size by Type (2020-2025)
4.2 Global Prenatal and Newborn Genetic Testing Forecasted Market Size by Type (2026-2031)
5 Prenatal and Newborn Genetic Testing Breakdown Data by Application
5.1 Global Prenatal and Newborn Genetic Testing Historic Market Size by Application (2020-2025)
5.2 Global Prenatal and Newborn Genetic Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Prenatal and Newborn Genetic Testing Market Size (2020-2031)
6.2 North America Prenatal and Newborn Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Prenatal and Newborn Genetic Testing Market Size by Country (2020-2025)
6.4 North America Prenatal and Newborn Genetic Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prenatal and Newborn Genetic Testing Market Size (2020-2031)
7.2 Europe Prenatal and Newborn Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Prenatal and Newborn Genetic Testing Market Size by Country (2020-2025)
7.4 Europe Prenatal and Newborn Genetic Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prenatal and Newborn Genetic Testing Market Size (2020-2031)
8.2 Asia-Pacific Prenatal and Newborn Genetic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Prenatal and Newborn Genetic Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Prenatal and Newborn Genetic Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prenatal and Newborn Genetic Testing Market Size (2020-2031)
9.2 Latin America Prenatal and Newborn Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Prenatal and Newborn Genetic Testing Market Size by Country (2020-2025)
9.4 Latin America Prenatal and Newborn Genetic Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prenatal and Newborn Genetic Testing Market Size (2020-2031)
10.2 Middle East & Africa Prenatal and Newborn Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Prenatal and Newborn Genetic Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Prenatal and Newborn Genetic Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Diagnostic
11.1.1 Roche Diagnostic Company Details
11.1.2 Roche Diagnostic Business Overview
11.1.3 Roche Diagnostic Prenatal and Newborn Genetic Testing Introduction
11.1.4 Roche Diagnostic Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025)
11.1.5 Roche Diagnostic Recent Development
11.2 Elitech Group
11.2.1 Elitech Group Company Details
11.2.2 Elitech Group Business Overview
11.2.3 Elitech Group Prenatal and Newborn Genetic Testing Introduction
11.2.4 Elitech Group Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025)
11.2.5 Elitech Group Recent Development
11.3 Myriad Genetics
11.3.1 Myriad Genetics Company Details
11.3.2 Myriad Genetics Business Overview
11.3.3 Myriad Genetics Prenatal and Newborn Genetic Testing Introduction
11.3.4 Myriad Genetics Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025)
11.3.5 Myriad Genetics Recent Development
11.4 Biocartis
11.4.1 Biocartis Company Details
11.4.2 Biocartis Business Overview
11.4.3 Biocartis Prenatal and Newborn Genetic Testing Introduction
11.4.4 Biocartis Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025)
11.4.5 Biocartis Recent Development
11.5 IntegraGen
11.5.1 IntegraGen Company Details
11.5.2 IntegraGen Business Overview
11.5.3 IntegraGen Prenatal and Newborn Genetic Testing Introduction
11.5.4 IntegraGen Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025)
11.5.5 IntegraGen Recent Development
11.6 Perkin Elmer
11.6.1 Perkin Elmer Company Details
11.6.2 Perkin Elmer Business Overview
11.6.3 Perkin Elmer Prenatal and Newborn Genetic Testing Introduction
11.6.4 Perkin Elmer Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025)
11.6.5 Perkin Elmer Recent Development
11.7 WaferGen Biosystem
11.7.1 WaferGen Biosystem Company Details
11.7.2 WaferGen Biosystem Business Overview
11.7.3 WaferGen Biosystem Prenatal and Newborn Genetic Testing Introduction
11.7.4 WaferGen Biosystem Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025)
11.7.5 WaferGen Biosystem Recent Development
11.8 Interpace Diagnostics
11.8.1 Interpace Diagnostics Company Details
11.8.2 Interpace Diagnostics Business Overview
11.8.3 Interpace Diagnostics Prenatal and Newborn Genetic Testing Introduction
11.8.4 Interpace Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025)
11.8.5 Interpace Diagnostics Recent Development
11.9 Quest Diagnostic
11.9.1 Quest Diagnostic Company Details
11.9.2 Quest Diagnostic Business Overview
11.9.3 Quest Diagnostic Prenatal and Newborn Genetic Testing Introduction
11.9.4 Quest Diagnostic Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025)
11.9.5 Quest Diagnostic Recent Development
11.10 Bio-Rad
11.10.1 Bio-Rad Company Details
11.10.2 Bio-Rad Business Overview
11.10.3 Bio-Rad Prenatal and Newborn Genetic Testing Introduction
11.10.4 Bio-Rad Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025)
11.10.5 Bio-Rad Recent Development
11.11 AutoGenomics
11.11.1 AutoGenomics Company Details
11.11.2 AutoGenomics Business Overview
11.11.3 AutoGenomics Prenatal and Newborn Genetic Testing Introduction
11.11.4 AutoGenomics Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025)
11.11.5 AutoGenomics Recent Development
11.12 Abbott
11.12.1 Abbott Company Details
11.12.2 Abbott Business Overview
11.12.3 Abbott Prenatal and Newborn Genetic Testing Introduction
11.12.4 Abbott Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025)
11.12.5 Abbott Recent Development
11.13 Cepheid
11.13.1 Cepheid Company Details
11.13.2 Cepheid Business Overview
11.13.3 Cepheid Prenatal and Newborn Genetic Testing Introduction
11.13.4 Cepheid Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025)
11.13.5 Cepheid Recent Development
11.14 EKF Diagnostics
11.14.1 EKF Diagnostics Company Details
11.14.2 EKF Diagnostics Business Overview
11.14.3 EKF Diagnostics Prenatal and Newborn Genetic Testing Introduction
11.14.4 EKF Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025)
11.14.5 EKF Diagnostics Recent Development
11.15 Natera
11.15.1 Natera Company Details
11.15.2 Natera Business Overview
11.15.3 Natera Prenatal and Newborn Genetic Testing Introduction
11.15.4 Natera Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025)
11.15.5 Natera Recent Development
11.16 Agilent Technologies
11.16.1 Agilent Technologies Company Details
11.16.2 Agilent Technologies Business Overview
11.16.3 Agilent Technologies Prenatal and Newborn Genetic Testing Introduction
11.16.4 Agilent Technologies Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025)
11.16.5 Agilent Technologies Recent Development
11.17 Illumina
11.17.1 Illumina Company Details
11.17.2 Illumina Business Overview
11.17.3 Illumina Prenatal and Newborn Genetic Testing Introduction
11.17.4 Illumina Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025)
11.17.5 Illumina Recent Development
11.18 Ariosa Diagnostics
11.18.1 Ariosa Diagnostics Company Details
11.18.2 Ariosa Diagnostics Business Overview
11.18.3 Ariosa Diagnostics Prenatal and Newborn Genetic Testing Introduction
11.18.4 Ariosa Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025)
11.18.5 Ariosa Diagnostics Recent Development
11.19 Sequenom
11.19.1 Sequenom Company Details
11.19.2 Sequenom Business Overview
11.19.3 Sequenom Prenatal and Newborn Genetic Testing Introduction
11.19.4 Sequenom Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025)
11.19.5 Sequenom Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Prenatal and Newborn Genetic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Array-Comparative Genetic Hybridization(aCGH)
 Table 3. Key Players of Fluorescence In-Situ Hybridization(FISH)
 Table 4. Key Players of Polymerase Chain Reaction(PCR)
 Table 5. Global Prenatal and Newborn Genetic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Prenatal and Newborn Genetic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Prenatal and Newborn Genetic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Prenatal and Newborn Genetic Testing Market Share by Region (2020-2025)
 Table 9. Global Prenatal and Newborn Genetic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Prenatal and Newborn Genetic Testing Market Share by Region (2026-2031)
 Table 11. Prenatal and Newborn Genetic Testing Market Trends
 Table 12. Prenatal and Newborn Genetic Testing Market Drivers
 Table 13. Prenatal and Newborn Genetic Testing Market Challenges
 Table 14. Prenatal and Newborn Genetic Testing Market Restraints
 Table 15. Global Prenatal and Newborn Genetic Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Prenatal and Newborn Genetic Testing Market Share by Players (2020-2025)
 Table 17. Global Top Prenatal and Newborn Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prenatal and Newborn Genetic Testing as of 2024)
 Table 18. Ranking of Global Top Prenatal and Newborn Genetic Testing Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Prenatal and Newborn Genetic Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Prenatal and Newborn Genetic Testing, Headquarters and Area Served
 Table 21. Global Key Players of Prenatal and Newborn Genetic Testing, Product and Application
 Table 22. Global Key Players of Prenatal and Newborn Genetic Testing, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Prenatal and Newborn Genetic Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Prenatal and Newborn Genetic Testing Revenue Market Share by Type (2020-2025)
 Table 26. Global Prenatal and Newborn Genetic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Prenatal and Newborn Genetic Testing Revenue Market Share by Type (2026-2031)
 Table 28. Global Prenatal and Newborn Genetic Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Prenatal and Newborn Genetic Testing Revenue Market Share by Application (2020-2025)
 Table 30. Global Prenatal and Newborn Genetic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Prenatal and Newborn Genetic Testing Revenue Market Share by Application (2026-2031)
 Table 32. North America Prenatal and Newborn Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Prenatal and Newborn Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Prenatal and Newborn Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Prenatal and Newborn Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Prenatal and Newborn Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Prenatal and Newborn Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Prenatal and Newborn Genetic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Prenatal and Newborn Genetic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Prenatal and Newborn Genetic Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Prenatal and Newborn Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Prenatal and Newborn Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Prenatal and Newborn Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Prenatal and Newborn Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Prenatal and Newborn Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Prenatal and Newborn Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Roche Diagnostic Company Details
 Table 48. Roche Diagnostic Business Overview
 Table 49. Roche Diagnostic Prenatal and Newborn Genetic Testing Product
 Table 50. Roche Diagnostic Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025) & (US$ Million)
 Table 51. Roche Diagnostic Recent Development
 Table 52. Elitech Group Company Details
 Table 53. Elitech Group Business Overview
 Table 54. Elitech Group Prenatal and Newborn Genetic Testing Product
 Table 55. Elitech Group Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025) & (US$ Million)
 Table 56. Elitech Group Recent Development
 Table 57. Myriad Genetics Company Details
 Table 58. Myriad Genetics Business Overview
 Table 59. Myriad Genetics Prenatal and Newborn Genetic Testing Product
 Table 60. Myriad Genetics Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025) & (US$ Million)
 Table 61. Myriad Genetics Recent Development
 Table 62. Biocartis Company Details
 Table 63. Biocartis Business Overview
 Table 64. Biocartis Prenatal and Newborn Genetic Testing Product
 Table 65. Biocartis Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025) & (US$ Million)
 Table 66. Biocartis Recent Development
 Table 67. IntegraGen Company Details
 Table 68. IntegraGen Business Overview
 Table 69. IntegraGen Prenatal and Newborn Genetic Testing Product
 Table 70. IntegraGen Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025) & (US$ Million)
 Table 71. IntegraGen Recent Development
 Table 72. Perkin Elmer Company Details
 Table 73. Perkin Elmer Business Overview
 Table 74. Perkin Elmer Prenatal and Newborn Genetic Testing Product
 Table 75. Perkin Elmer Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025) & (US$ Million)
 Table 76. Perkin Elmer Recent Development
 Table 77. WaferGen Biosystem Company Details
 Table 78. WaferGen Biosystem Business Overview
 Table 79. WaferGen Biosystem Prenatal and Newborn Genetic Testing Product
 Table 80. WaferGen Biosystem Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025) & (US$ Million)
 Table 81. WaferGen Biosystem Recent Development
 Table 82. Interpace Diagnostics Company Details
 Table 83. Interpace Diagnostics Business Overview
 Table 84. Interpace Diagnostics Prenatal and Newborn Genetic Testing Product
 Table 85. Interpace Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025) & (US$ Million)
 Table 86. Interpace Diagnostics Recent Development
 Table 87. Quest Diagnostic Company Details
 Table 88. Quest Diagnostic Business Overview
 Table 89. Quest Diagnostic Prenatal and Newborn Genetic Testing Product
 Table 90. Quest Diagnostic Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025) & (US$ Million)
 Table 91. Quest Diagnostic Recent Development
 Table 92. Bio-Rad Company Details
 Table 93. Bio-Rad Business Overview
 Table 94. Bio-Rad Prenatal and Newborn Genetic Testing Product
 Table 95. Bio-Rad Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025) & (US$ Million)
 Table 96. Bio-Rad Recent Development
 Table 97. AutoGenomics Company Details
 Table 98. AutoGenomics Business Overview
 Table 99. AutoGenomics Prenatal and Newborn Genetic Testing Product
 Table 100. AutoGenomics Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025) & (US$ Million)
 Table 101. AutoGenomics Recent Development
 Table 102. Abbott Company Details
 Table 103. Abbott Business Overview
 Table 104. Abbott Prenatal and Newborn Genetic Testing Product
 Table 105. Abbott Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025) & (US$ Million)
 Table 106. Abbott Recent Development
 Table 107. Cepheid Company Details
 Table 108. Cepheid Business Overview
 Table 109. Cepheid Prenatal and Newborn Genetic Testing Product
 Table 110. Cepheid Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025) & (US$ Million)
 Table 111. Cepheid Recent Development
 Table 112. EKF Diagnostics Company Details
 Table 113. EKF Diagnostics Business Overview
 Table 114. EKF Diagnostics Prenatal and Newborn Genetic Testing Product
 Table 115. EKF Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025) & (US$ Million)
 Table 116. EKF Diagnostics Recent Development
 Table 117. Natera Company Details
 Table 118. Natera Business Overview
 Table 119. Natera Prenatal and Newborn Genetic Testing Product
 Table 120. Natera Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025) & (US$ Million)
 Table 121. Natera Recent Development
 Table 122. Agilent Technologies Company Details
 Table 123. Agilent Technologies Business Overview
 Table 124. Agilent Technologies Prenatal and Newborn Genetic Testing Product
 Table 125. Agilent Technologies Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025) & (US$ Million)
 Table 126. Agilent Technologies Recent Development
 Table 127. Illumina Company Details
 Table 128. Illumina Business Overview
 Table 129. Illumina Prenatal and Newborn Genetic Testing Product
 Table 130. Illumina Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025) & (US$ Million)
 Table 131. Illumina Recent Development
 Table 132. Ariosa Diagnostics Company Details
 Table 133. Ariosa Diagnostics Business Overview
 Table 134. Ariosa Diagnostics Prenatal and Newborn Genetic Testing Product
 Table 135. Ariosa Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025) & (US$ Million)
 Table 136. Ariosa Diagnostics Recent Development
 Table 137. Sequenom Company Details
 Table 138. Sequenom Business Overview
 Table 139. Sequenom Prenatal and Newborn Genetic Testing Product
 Table 140. Sequenom Revenue in Prenatal and Newborn Genetic Testing Business (2020-2025) & (US$ Million)
 Table 141. Sequenom Recent Development
 Table 142. Research Programs/Design for This Report
 Table 143. Key Data Information from Secondary Sources
 Table 144. Key Data Information from Primary Sources
 Table 145. Authors List of This Report


List of Figures
 Figure 1. Prenatal and Newborn Genetic Testing Picture
 Figure 2. Global Prenatal and Newborn Genetic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Prenatal and Newborn Genetic Testing Market Share by Type: 2024 VS 2031
 Figure 4. Array-Comparative Genetic Hybridization(aCGH) Features
 Figure 5. Fluorescence In-Situ Hybridization(FISH) Features
 Figure 6. Polymerase Chain Reaction(PCR) Features
 Figure 7. Global Prenatal and Newborn Genetic Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Prenatal and Newborn Genetic Testing Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Diagnostic Organization Case Studies
 Figure 11. Other Case Studies
 Figure 12. Prenatal and Newborn Genetic Testing Report Years Considered
 Figure 13. Global Prenatal and Newborn Genetic Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Prenatal and Newborn Genetic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Prenatal and Newborn Genetic Testing Market Share by Region: 2024 VS 2031
 Figure 16. Global Prenatal and Newborn Genetic Testing Market Share by Players in 2024
 Figure 17. Global Top Prenatal and Newborn Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prenatal and Newborn Genetic Testing as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Prenatal and Newborn Genetic Testing Revenue in 2024
 Figure 19. North America Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Prenatal and Newborn Genetic Testing Market Share by Country (2020-2031)
 Figure 21. United States Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Prenatal and Newborn Genetic Testing Market Share by Country (2020-2031)
 Figure 25. Germany Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Prenatal and Newborn Genetic Testing Market Share by Region (2020-2031)
 Figure 33. China Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Prenatal and Newborn Genetic Testing Market Share by Country (2020-2031)
 Figure 41. Mexico Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Prenatal and Newborn Genetic Testing Market Share by Country (2020-2031)
 Figure 45. Turkey Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Prenatal and Newborn Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Roche Diagnostic Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2020-2025)
 Figure 49. Elitech Group Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2020-2025)
 Figure 50. Myriad Genetics Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2020-2025)
 Figure 51. Biocartis Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2020-2025)
 Figure 52. IntegraGen Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2020-2025)
 Figure 53. Perkin Elmer Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2020-2025)
 Figure 54. WaferGen Biosystem Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2020-2025)
 Figure 55. Interpace Diagnostics Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2020-2025)
 Figure 56. Quest Diagnostic Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2020-2025)
 Figure 57. Bio-Rad Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2020-2025)
 Figure 58. AutoGenomics Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2020-2025)
 Figure 59. Abbott Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2020-2025)
 Figure 60. Cepheid Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2020-2025)
 Figure 61. EKF Diagnostics Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2020-2025)
 Figure 62. Natera Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2020-2025)
 Figure 63. Agilent Technologies Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2020-2025)
 Figure 64. Illumina Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2020-2025)
 Figure 65. Ariosa Diagnostics Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2020-2025)
 Figure 66. Sequenom Revenue Growth Rate in Prenatal and Newborn Genetic Testing Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS